These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 15741434

  • 1. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
    Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P.
    Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of budesonide on inflammatory status in COPD.
    Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE.
    COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
    [Abstract] [Full Text] [Related]

  • 3. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.
    Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, Pavord ID.
    Lancet; 2000 Oct 28; 356(9240):1480-5. PubMed ID: 11081531
    [Abstract] [Full Text] [Related]

  • 4. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
    Reid DW, Wen Y, Johns DP, Williams TJ, Ward C, Walters EH.
    Respirology; 2008 Nov 28; 13(6):799-809. PubMed ID: 18811878
    [Abstract] [Full Text] [Related]

  • 5. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
    John M, Bosse S, Oltmanns U, Schumacher A, Witt C.
    Respir Med; 2005 Nov 28; 99(11):1418-24. PubMed ID: 15894479
    [Abstract] [Full Text] [Related]

  • 6. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment.
    Leigh R, Pizzichini MM, Morris MM, Maltais F, Hargreave FE, Pizzichini E.
    Eur Respir J; 2006 May 28; 27(5):964-71. PubMed ID: 16446316
    [Abstract] [Full Text] [Related]

  • 7. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
    Brightling CE, Bleecker ER, Panettieri RA, Bafadhel M, She D, Ward CK, Xu X, Birrell C, van der Merwe R.
    Lancet Respir Med; 2014 Nov 28; 2(11):891-901. PubMed ID: 25208464
    [Abstract] [Full Text] [Related]

  • 8. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
    Basyigit I, Yildiz F, Ozkara SK, Boyaci H, Ilgazli A.
    Mediators Inflamm; 2004 Aug 28; 13(4):285-91. PubMed ID: 15545060
    [Abstract] [Full Text] [Related]

  • 9. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.
    Hothersall EJ, Chaudhuri R, McSharry C, Donnelly I, Lafferty J, McMahon AD, Weir CJ, Meiklejohn J, Sattar N, McInnes I, Wood S, Thomson NC.
    Thorax; 2008 Dec 28; 63(12):1070-5. PubMed ID: 18757458
    [Abstract] [Full Text] [Related]

  • 10. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
    Jiang YW, Sun YC, Zhou QT, Gai XY, Cao WL, Yao WZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun 28; 30(6):447-51. PubMed ID: 17673020
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D.
    Thorax; 2009 Mar 28; 64(3):216-23. PubMed ID: 19052054
    [Abstract] [Full Text] [Related]

  • 12. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
    Karpel JP, Busse WW, Noonan MJ, Monahan ME, Lutsky B, Staudinger H.
    Ann Pharmacother; 2005 Dec 28; 39(12):1977-83. PubMed ID: 16264062
    [Abstract] [Full Text] [Related]

  • 13. Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD).
    Grönke L, Schlenker J, Holz O, Out TA, Magnussen H, Jörres RA.
    Respir Med; 2005 Oct 28; 99(10):1241-8. PubMed ID: 16140224
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    van Overveld FJ, Demkow U, Górecka D, de Backer WA, Zielinski J.
    J Physiol Pharmacol; 2005 Sep 28; 56 Suppl 4():135-42. PubMed ID: 16204787
    [Abstract] [Full Text] [Related]

  • 19. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
    Duffy N, Walker P, Diamantea F, Calverley PM, Davies L.
    Thorax; 2005 Sep 28; 60(9):713-7. PubMed ID: 15939732
    [Abstract] [Full Text] [Related]

  • 20. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
    Basyigit I, Yildiz F, Ozkara SK, Yildirim E, Boyaci H, Ilgazli A.
    Ann Pharmacother; 2004 Sep 28; 38(9):1400-5. PubMed ID: 15252191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.